top of page
Report.png
Ligase Enzymes Market

Ligase Enzymes Market Size, Share, Competitive Landscape and Trend Analysis Report by Source, Application and End Users: Global Opportunity and Industry Forecast (2025-2032)

Report ID:

1170

Industry:

Healthcare

Published on:

March 2026

Ligase Enzymes Market had a value of USD 0.30 billion in 2025 and expected it to hit USD 0.44 billion by 2032, with a CAGR of 6.5% through the forecast period.

Ligase Enzymes Trends and Analytical Insights -

  • North America Ligase Enzymes Market was the largest revenue generating region market in year 2025, with market share accounted for 41 %.

  • In 2025, By Source segment, Microorganism dominated the Ligase Enzymes, accounted for 58 % market shares.

  • Leading Key players for Ligase Enzymes Market in 2025 was Advanced Enzyme Technologies Ltd., Agilent Technologies Inc., Amano Enzyme Inc. and ArcticZymes Technologies ASA

Ligase Enzymes Market Size & Forecast

  • Market Size 2025: USD 0.30 Billion

  • Projected Market Size 2032: USD 0.44 Billion

  • CAGR (2025-2032): 6.5%

  • North America: Dominating market in 2025

Ligase Enzymes Market Overview

The global Ligase Enzymes market was conducting research, development, and commercialization of ligase enzymes utilized in molecular and genetic engineering. Ligase enzymes serve as key biomolecules that enable the linking of (DNA) and (RNA) by creating phosphodiester bonds. Ligase enzymes are critical to laboratory diagnostics, cloning, polymerase chain reaction workflows, mutation analysis, and next-generation sequencing techniques. By 2025, over 75% of molecular laboratories globally routinely utilize DNA ligase in scientific and clinical research protocols. Biotechnology laboratories continue to grow by approximately 6% per year from 2020 through 2025.

Rising genomic studies and developments in the enzymatic ligase enzymes sector have led to an increase in Ligase Enzyme purchasing activity. In 2023, it is estimated that there would be over 45 million genomic sequences produced globally, up from 28 million produced in 2019. Pharmaceutical companies continue to increase their investment in R&D by nearly 8% each year, further boosting the Ligase Enzymes revenues from the procurement of enzymes by those companies. Workflow improvements resulting from laboratory automation have increased the efficiency of the laboratories by nearly 20%. The increase in the number of high-throughput laboratories over traditional laboratories has resulted in high-throughput laboratories using approximately 12% more enzymes than traditional laboratories. The number of government-funded research projects utilizing Ligase Enzymes has grown significantly as there are now over 40 countries that have government-funded research projects relying on Ligase Enzymes to develop enzyme-based molecular techniques. Synthetic biology programs continue to develop at an accelerated rate; as a result, these developments are adding to the economic viability of Ligase Enzymes within all biotech companies and research organizations.

Ligase Enzymes Market Dynamic’s

The demand for ligase enzymes has been rising significantly due to increasing numbers of genetic research initiatives as well as growth in the use of automated laboratory equipment. Currently, more than 60% of the biotechnology start-ups that have received financing since 2021 are utilizing ligase-based methods to assemble their DNAs. During this same period, approximately 15% healthcare diagnostic testing volume based on polymerase chain reactions (PCR) was increasing each year causing a corresponding increase in demand for ligase enzymes in clinical laboratories. The widespread use of DNA ligases and recombinant DNA technology worldwide has greatly contributed to the vaccine and therapeutic protein production. Current clinical trials for gene therapy are exceeding 2,000 globally, up from nearly 1,200 in 2017. There continues to be an average annual increase of 9% in the number of academic research papers published that reference applications for ligases. Currently, there are over 70 countries that are utilizing sequencing platforms and providing consistency in demand for enzyme kits. Additionally, use of automated systems to perform reactions within very large laboratories has improved both accuracy and throughput efficiency.

Ligase enzymes were having difficulties operationally due to issues surrounding the stability of enzymes as well as their storage requirements. The majority of the ligase enzymes require -20 degrees Celsius to -80 degrees Celsius cold-chain storage, which is leading to nearly a 10% rise in logistics costs. Batch consistency issues and limited shelf-life are affecting how research facilities are purchasing enzymes and how they are using them in the lab. Enzyme engineering initiatives have been working towards solving these issues. As of 2023, research facilities were launching 12 new recombinant ligase variants, which are producing higher enzyme stability than previously seen at 25 degrees Celsius for short periods of time. Lyophilized enzyme formulations are providing approximately 18% more flexibility in storage than traditional liquid forms. Emerging economies are providing approximately 7% annual growth in biotech funding, and domestic enzyme manufacturing is becoming stronger as a result. Synthetic Biology research programs are investing in gene assembly platforms, and point-of-care diagnostic development is creating new opportunities for ligase-based detection systems.

As the Ligase Enzymes Market research indicates recent technological advancements have been made in this field. Biotechnology firms have launched ligase kits with a 30% increase in reaction times from previous kits which were released in 2025. Co-products made using automation-compatible formats have a throughput efficiency increase of approximately 25% for advanced laboratory settings. Multiplex diagnostic kits integrating ligase enzymes for mutation detection and infectious disease screening have been developed using ligase enzymes to improve clinical diagnostic testing capabilities. Over the last three years there have been more than 15 strategic partnerships announced between enzyme suppliers and genomic technology vendors. The development time is reduced by 20% based on current use of AI-assisted enzyme design platforms. In addition, many research institutions are working with private companies to develop efficient microbial fermentation processes that have increased production efficiency by 12%. Overall, these improvements in technologies give an optimistic long term forecast for the Ligase Enzymes Market.

Ligase Enzymes Market Segment Analysis

The Ligase Enzymes Market segmented into by Source, Application and End User.

By Source,

Based on source, the market was divided into Microorganisms and Animal and Plant Ligases. In 2025, the Microorganism segment of Ligase Enzymes was leading Ligase Enzyme Market with approximately 58% of the total Ligase Enzyme Market Share. The majority of Ligase Enzymes that are produced through recombinant methods and fermentations at a large scale are derived from Microorganisms. There was a 14% increase in Industrial Fermentation systems generating Microbial ligases from 2022 to 2025. The ligases produce enzymes that have consistent purity, increased yields, and are cost effective to produce. Microbial strains are being modified genetically to enhance their ability to produce ligases. Animals and plants are used in specific applications; however, Microorganisms are commonly used in laboratory operations. The Microorganism Segment of Ligase Enzymes has retained its high level of growth through the use of customizable and efficient manufacturing processes as well as maintaining the leading position in General Ligase Enzymes Market.

By Application,

The Ligase Enzymes Market can be segmented according to Application: Polymerase Chain Reaction, Cloning, Mutation Detection, Next-generation Sequencing, and Drug Target. Polymerase Chain Reaction will remain the largest segment within the Ligase Enzymes Market, accounting for 34% of the overall market in 2025. The volume of Diagnostic and Research Testing conducted via PCR is increasing significantly at hospitals and laboratories; over 2.5 billion PCR tests were performed worldwide in 2023 for infectious disease and genetic screening purposes. Ligase enzymes are utilized in both the ligase chain reaction and DNA repair workflows. In addition, both Mutation Detection and Next-generation Sequencing will also contribute to the demand for ligase enzymes. Despite the use of ligase enzymes in both Mutation Detection and Next-generation Sequencing, however, PCR-based applications will continue to be used most frequently within Molecular Labs. The ongoing integration of automated PCR systems will support the continued dominance of the PCR market segment in the Ligase Enzymes Market.

Ligase Enzymes Market Region Analysis

Ligase Enzymes Market in North America was led by North America with a global market share of 41% in 2025. Biotech China contributed more than $70 billion in public and private funding every year for Life Sciences Biotech; furthermore, more than 50% of worldwide genomic sequencing occurs in the USA. The approximately 1,200 active Gene Therapy clinical trial sites in 2020 have increased the volume of Enzyme Utilization through enhanced laboratory infrastructure and automation of Molecular Platforms used for gene sequencing. Academic institutions accounted for approximately 30% of all global Molecular Biology Publications per year done in North America; consequently, Registered Biotech Companies and Diagnostic Manufactures continue to improve their Distribution Channels & Manufacturing Capabilities to meet this demand. Overall, development of Innovative Biotechnology and Government Support of Research & Development Expenditures are major factors contributing to North America's position as the global leader in the Ligase Enzymes Market.

Ligase Enzymes Market Competitive Analysis

The Ligase Enzymes market has shown a competitive structure through innovations and strategic partnerships among the major manufacturers. Most companies spend about 10% of their yearly revenues on developing thermostable and high-fidelity ligase variants through research. Several companies have entered into partnerships with genomic technology firms to develop platforms for sequencing and diagnostics by including ligases in the application. To improve fermentation yields and purity of the enzyme, many firms are upgrading their manufacturing facilities. Mergers and acquisitions will be pursued to enhance product lines and networks for global distribution. The ligase enzyme industry is also emphasizing the development of automation-compatible kits for laboratories. Competitive environments in the ligase enzyme sector will be characterized by constant product development and research collaborations among manufacturers.

Ligase Enzymes Market Scope:

Key Players –

Frequently Ask Questions –

1. What was the Ligase Enzymes Market?Ans - The Ligase Enzymes Market was representing the global industry that was producing ligase enzymes for molecular biology and diagnostics.

2. What factors were driving the Ligase Enzymes Market?Ans - Increasing genomic research, PCR testing volumes, and gene therapy trials were driving the Ligase Enzymes Market.

3. Which source segment was leading the Ligase Enzymes Market?Ans - The Microorganisms segment was leading the Ligase Enzymes Market with strong production efficiency.

4. Which application was dominating the Ligase Enzymes Market?Ans - Polymerase Chain Reaction was dominating the Ligase Enzymes Market in 2025.

5. Which region was leading the Ligase Enzymes Market?Ans - North America was leading the Ligase Enzymes Market with advanced R&D infrastructure.

Report Payment

Single User:
$4199
Spreadsheet:
$2900
Corporate User:
$5500
bottom of page